COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 2124: Articles 21231-21240  | Next

A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
Dubee, V., Roy, P.-M., Vielle, B., Parot-Schinkel, E., Blanchet, O., Darsonval, A., Lefeuvre, C., Abbara, C., Boucher, S., Devaud, E., Robineau, O., Rispal, P., Guimard, T., D'Anglejan, E., Diamantis, S., Custaud, M.-A., Pellier, I., Mercat, A.
10.1101/2020.10.19.20214940 — Posted: 2020-10-21 Discussion: Onsite
Dietary Nicotianamine as a Factor in International Variations of Mortality from Covid-19
Day, C. E.
10.1101/2020.10.15.20213470 — Posted: 2020-10-20
Viral surface geometry shapes influenza and coronavirus spike evolution
Amitai, A.
10.1101/2020.10.20.347641 — Posted: 2020-10-20
Impact of clade specific mutations on structural fidelity of SARS-CoV-2 proteins
Basu, S., Mukhopadhyay, S., Das, R., Mukhopadhyay, S., Singh, P. K., Ganguli, S.
10.1101/2020.10.20.347021 — Posted: 2020-10-20
Single-cell RNA-sequencing reveals dysregulation of molecular programs associated with SARS-CoV-2 severity and outcomes in patients with chronic lung disease
Bui, L. T., Winters, N. I., Chung, M.-I., Joseph, C., Gutierrez, A. J., Habermann, A. C., Adams, T. S., Schupp, J. C., Poli, S., Peter, L. M., Taylor, C. J., Blackburn, J. B., Richmond, B. W., Nicholson, A. G., Rassl, D., Wallace, W. A., Rosas, I. O., Jenkins, R. G., Kaminski, N., Kropski, J. A., Banovich, N. E., Human Cell Atlas Lung Biological Network
10.1101/2020.10.20.347187 — Posted: 2020-10-20
High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples
Anand, S. P., Prevost, J., Richard, J., Perreault, J., Tremblay, T., Drouin, M., Fournier, M.-J., Lewin, A., Bazin, R., Finzi, A.
10.1101/2020.10.20.346783 — Posted: 2020-10-20
Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein
Wang, C., van Haperen, R., Gutierrez-Alvarez, J., Li, W., Okba, N., Albulescu, I., Widjaja, I., van Dieren, B., Fernandez-Delgado, R., Sola, I., Hurdiss, D., Daramola, O., Grosveld, F., van Kuppeveld, F., Haagmans, B., Enjuanes, L., Drabek, D., Bosch, B.-J.
10.1101/2020.10.20.346916 — Posted: 2020-10-20
Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction
Fernandes, B. H. V., Feitosa, N. M., Barbosa, A. P., Bomfim, C. G., Garnique, A. M., Gomes, F. I., Nakajima, R. T., Belo, M. A., Eto, S. F., Fernandes, D. C., Malafaia, G., Manrique, W. G., Conde, G., Rosales, R. R., Todeschini, I., Rivero, I., Llontop, E., Sgro, G. G., Oka, G. U., Bueno, N. F., Ferraris, F. K., de Magalhaes, M. T., Medeiros, R. J., Gomes, J. M., Junqueira, M. S., Conceicao, K., Pontes, L. G., Neto, A. C., Perez, A. C., Barcellos, L. G., Junior, J. D. C., Dorlass, E. G., Camara, N. O., Durigon, E. L., Cunha, F. Q., Nobrega, R. H., Machado-Santelli, G. M., Farah, C. S., Veras, F. P., Galindo-Villegas, J., Costa-Lotufo, L., Cunha, T. M., Chammas, R., Carvalho, L. R., Guzzo, C. R., Charlie-Silva, I.
10.1101/2020.10.20.346262 — Posted: 2020-10-20
The Response of Pakistani Social Workers amid the COVID-19 Pandemic: A Qualitative Analysis of the Main Challenges
Abbas, K., UlHaq, M. I., Zaidi, W. A., Kaleem, A., Sohail, H., Ahmed, M.
10.1101/2020.10.18.20214601 — Posted: 2020-10-20
Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
Gremmels, H., Winkel, B. M. F., Schuurman, R., Rosingh, A., Rigter, N. A. M., Rodriguez, O., Ubijaan, J., Wensing, A. M. J., Bonten, M. J. M., Hofstra, L. M.
10.1101/2020.10.16.20214189 — Posted: 2020-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).